News | Radiation Dose Management | October 29, 2015

Mirada Medical, BTG Collaborate on Dosimetry Software for Radioembolization Therapy

Software will provide a more personalized approach to radioembolization for liver cancer patients

Mirada Medical, BTG plc, collaboration, dosimetry software for radioembolization therapy, liver cancer patients

October 29, 2015 — Mirada Medical Ltd, a medical imaging software company, and BTG plc, a global specialist healthcare company, announced a collaboration to develop dosimetry software solutions to optimize radioembolization therapy with TheraSphere.

Both companies are working together to provide a more personalized approach to radioembolization for liver cancer patients through easy-to-use and bespoke software that helps physicians plan the delivery of a specific radiation dose based on an individual patient’s need. 

Matthieu Leclerc-Chalvet, Mirada Medical managing director commented “Our goal is to provide intuitive software that facilitates the clinician’s use of multimodal images to plan radioembolization therapy with the ultimate aim of leading to better patient outcomes. The collaboration with BTG leverages our image processing expertise and highlights the importance of imaging for planning treatments.”

The companies plan to make the software available in 2016.

For more information: www.mirada-medical.com

Related Content

The Aquilion Precision CT system from Canon offers very high resolution imaging, which may aid in cancer detection and improved treatment planning in radiation oncology. #ASTRO2018 #ASTRO #ASTRO18

The Aquilion Precision CT system from Canon offers very high resolution imaging, which may aid in cancer detection and improved treatment planning in radiation oncology. 

News | Computed Tomography (CT) | October 19, 2018
October 19, 2018 – At the 2018 American Society of...
IBA's Proteus system and proton therapy solutions will be discussed at ASTRO 2018. #ASTRO18 #ASTRO #ASTRO2018
News | Proton Therapy | October 19, 2018
October 19, 2018 – IBA (Ion Beam Applications S.A.) is sharing how hospitals can secure performance, investment and t
IBA Dosimetry Enters Interoperability Agreement With Varian for Dolphin Monitoring
News | Radiation Therapy | October 17, 2018
IBA (Ion Beam Applications S.A.) announced it has entered into an agreement with Varian with the goal of validating the...
Boston Scientific Closes Acquisition of Augmenix Inc.
News | Prostate Cancer | October 17, 2018
Boston Scientific Corp. announced the close of its acquisition of Augmenix Inc., developer of the SpaceOAR Hydrogel...
Varian Expands Cancer Care Portfolio With Noona Healthcare Acquisition
News | Patient Engagement | October 15, 2018
Varian announced the acquisition of privately-held software company Noona Healthcare, developer of a cloud-based,...
New Guideline for Prostate Cancer Supports Shortened Radiation Therapy
News | Prostate Cancer | October 12, 2018
Three prominent medical societies issued a new clinical guideline for physicians treating men with early-stage prostate...
Surgery, Radiation Therapy Equally Effective in Treating Oropharyngeal Cancer
News | Radiation Therapy | October 09, 2018
A new study by researchers at UT Southwestern Medical Center found no major long-term differences in the effectiveness...
Videos | Treatment Planning | October 08, 2018
Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology at Henry Ford Health System, descri